Top Markets
Coin of the day
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
株式のランク #18092
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
株価
$10.22
最終同期: 2026-07-31
時価総額
$212.97M
変化(1日)
4.58%
変化(1年)
78.08%
CA
取引 Satellos Bioscience Inc. (MSCL)

カテゴリー

Satellos Bioscience Inc.(MSCL)の株価履歴
終値の最高値: $9.26 (2026-07-01)

終値の最安値: $152.54 (2008-01-01)
Satellos Bioscience Inc. の株価履歴(2008 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 29.26%
2025 -20.28%
2024 84.25%
2023 91.27%
2022 -80.10%
2021 2.79%
2020 -11.41%
2019 10.94%
2018 37.66%
2017 -27.41%
2016 41.02%
2015 -8.55%
2014 -90.26%
2013 -52.35%
2012 195.82%
2011 -36.68%
2010 -30.40%
2009 333.63%
2008 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.31 -8.76%
AU
$757.71 6.76%
CH